Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-409-2 | CAS number: 1329-99-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key studies were conducted with Depanol I for acute oral, inhalation and dermal toxicity. In all studies, LD50 or LC50 values were above limit dose, therefore Depanol I is safe and does not have any acute hazard potential.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to GLP and valid methods, therefore it is considered relevant, reliable and adequate for classification.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Wistar – HsdCpb: WU
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Toxicology, Department of Safety Assessment, Advinus Therapeutics Limited, Bangalore 560 058, India
- Age at study initiation: 9 to 10 weeks at treatment
- Weight at study initiation: 185.40 – 200.17 g
- Fasting period before study: Yes, 16-18 hours; water was not withheld. Food was offered 3-4 hours after dosing.
- Housing: Individually in standard polysulfone cages (Size: approximately L 425 x B 266 x H 175 mm), with stainless steel top grill having facilities for pelletted food and drinking water. Bedding: steam sterilized clean paddy husk was used and changed along with the cage twice a week.
- Diet (e.g. ad libitum): Teklad Certified (2014C) Global 14% Protein Rodent Maintenance Diet - Pellet (Certified) manufactured by Harlan Laboratories B.V. Maasheseweg 87c PO Box 553, 5800, AN Venray, The Netherland; ad libitum.
- Water (e.g. ad libitum): Deep bore-well water passed through activated charcoal filter and exposed to UV rays in Aquaguard on-line water filter-cum-purifier manufactured by Eureka Forbes Ltd, Mumbai 400 001, India, in polycarbonate bottles with stainless steel sipper tubes; ad libitum.
- Acclimation period: From 5 to 7 days under laboratory condition after physical examination
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-23°C
- Humidity (%): 58-67%
- Air changes (per hr): 12-15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: August 9, 2012 To: August 30, 2012 - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/mL
- Amount of vehicle (if gavage):
- Justification for choice of vehicle: A quantity of 1.0 g of the test item was mixed with Milli-Q water and the volume made up to 5 mL. The test item was not miscible.
Hence a quantity of 1 g of test item was mixed with corn oil and the volume was made up to 5 mL to get the test item concentration of 200 mg/mL suspension. The test item formed a visibly homogenous suspension. Hence, corn oil was used as the vehicle to prepare the test item suspension.
- Lot/batch no. (if required): MKBG9425V
DOSAGE PREPARATION (if unusual): The test item suspension was prepared on each day of the test item administration. A quantity of 4.0 g of the test item was mixed by adding small quantity of the selected vehicle (corn oil) and the volume made up to 20 mL to get the test item concentration of 200 mg/mL suspension. Homogeneity of the test item in the vehicle was maintained by mixing, using glass rod, prior to treatment. Preparation was made prior (within 1 hour) to dosing.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: As per the Material Safety Data Sheet provided by the Sponsor, the Acute Oral toxicity (mg/kg) in mouse is >2000 mg/kg body weight, hence the test was started as per Annex 2d of the OECD 423. The starting dose was 2000 mg/kg body weight with 3 animals /step. - Doses:
- 2000mg/kg bw
- No. of animals per sex per dose:
- 3 females per treatment step
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations: 5x on test day 1 and 1x daily during days 2-15 post administration; Weighing: on test day 1 (pre-administration), day 8 (7 days post administration) and day 15 (14 days post administration).
- Necropsy of survivors performed: yes - Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: as per LD50 cut-off value
- Mortality:
- No pre-terminal deaths.
- Clinical signs:
- other: No clinical signs.
- Gross pathology:
- No abnormality was detected at necropsy in control and treatment groups.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Depanol I has an oral LD50 of >2000 mg/kg body weight and does not have to be classified as per CLP Regulation.
- Executive summary:
The acute oral toxicity study with Depanol I in Wistar rats was tested according to the acute toxic class method. The test item suspended in corn oil was administered as oral gavage to overnight fasted (16 – 18 hours) 3 female rats at the dose of 2000 mg/kg body weight. Vehicle control group animals were administered corn oil. There were no toxic signs and pre-terminal deaths in treatment and control groups. Three additional female rats were tested at the same dose of 2000 mg/kg body weight. There were no toxic signs and pre-terminal deaths in treated and control groups. All animals of both groups gained body weight during 14 days observation period.
The rats of treatment and control groups were subjected to necropsy at termination and there were no abnormalities detected.
Based on the results of the present study, the test item, Depanol I has an oral LD50 of >2000 mg/kg body weight and does not have to be classified as per CLP Regulation.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- High quality study
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to GLP and valid methods, therefore it is considered relevant, reliable and adequate for classification.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.2 (Acute Toxicity (Inhalation))
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Wistar rats- HsdCpb:WU
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Toxicology, Department of Safety Assessment, Advinus Therapeutics Limited, Bangalore 560 058, India
- Age at study initiation: At exposure: 10-11 weeks
- Weight at study initiation: At grouping: Males: 270.83 – 285.26 g; Females: 212.92 – 225.78 g
At start of treatment: Males: 273.28 – 287.01 g; Females: 214.86 – 227.77 g
- Fasting period before study: Food and water were withheld during the exposure period.
- Housing:Individually in standard polysulfone cages (Size: approximately L 425 x B 266 x H 175mm), with stainless steel top grill having facilities for pelletted food and drinking water; Bedding: steam sterilized corn cob was used and changed along with the cage twice a week.
- Diet (e.g. ad libitum): Teklad Certified (2014C) Global 14% Protein Rodent Maintenance Diet- Pellet (Certified) manufactured by Harlan Laboratories B.V. Maasheseweg 87c PO Box 553, 5800, AN Venray, The Netherlands.
- Water (e.g. ad libitum): Deep bore-well water passed through activated charcoal filter and exposed to UV rays in ‘Aquaguard’ on-line water filter-cum-purifier manufactured by Eureka Forbes Ltd., Mumbai 400 001, India.
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24°C
- Humidity (%): 65-68%
- Air changes (per hr): 12-15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 2-10-2012 To: 24-10-2012 - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- other: Milli-Q water
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: glass atomizer; injection rate of 0.4 mL/min with 1.4 kg/cm2 of atomizer pressure.
The equipment, nose only exposure chamber is made of two stainless steel cylindrical chambers with 24 exposure ports in 4 tiers (6 ports per tier) to house up to 24 animals. The equipment consists of two chambers, i.e. the aerosol inlet chamber and the aerosol exhaust chamber. The chambers are cylindrical in shape and placed one next to the other. The chamber has 24 ports into a central plenum arranged as 4 horizontal rows centered on the sides of the cylindrical chamber. Within the plenum is a central tube into which the aerosol enters at each port. Air flow carries the aerosol to the nose of the animals restrained in position at the open ends of the tubes. The plexiglass restrainers with the animals are housed in an outer chamber.This chamber is made up of cylindrical plexiglass cover with an opening to fix the restrainers to the central plenum. The chamber has temperature and humidity control devices, and the temperature and the humidity where the animals are housed can be controlled and monitored.
- Exposure chamber volume: The approximate rat restrainer size for males: length 19.0 cm, diameter 6.0 cm and for females: length 15.0 cm, diameter 6.0 cm.
- Method of holding animals in test chamber: The animal restrainers are made of polycarbonate tubes for individual exposure tubes.
- Source and rate of air: The airflow rate was monitored continuously and the airflow of 20 L/min was maintained.
- Method of conditioning air: Aerosol not breathed and expired air pass into the plenum chamber (aerosol exhaust chamber) and from there, via filters, to the exhaust system.
- System of generating particulates/aerosols: A glass atomizer was used.
- Method of particle size determination: GALAI CIS-50 particle size analyzer; Laser based ‘Time-of-Transition Theory’;
- Treatment of exhaust air: Passed via filters to the exhaust system.
- Temperature: Inner chamber: 20.0-21.2 °C; Outer chamber: 20.3-21.1 °C.
Humidity: Inner chamber: 64.45 - 67.23 °C; Outer chamber: 64.85 - 67.65 °C.
TEST ATMOSPHERE
- Brief description of analytical method used: Aerosol samples were drawn from one port at hourly intervals of the 4 hour exposure period. The chamber air was passed through the sampling column which contains the silica gel (60–120 mesh size: approximately 16-20 gm) by suction applied using vacuum pump at a rate of 10 L/min for 10 minutes. The test item concentration in the air inhalation sample columns were analyzed using a validated analytical method.
The test item concentration in the air inhalation sample columns were analyzed using a validated analytical method.
The inhalation columns were eluted with Ethyl acetate. The concentration of Depanol I was determined by using Gas Chromatograph (GC) equipped with FID detector, auto sampler and a PC based data system.
- Samples taken from breathing zone: Yes.
VEHICLE
- Composition of vehicle (if applicable): Milli-Q water
TEST ATMOSPHERE
- Particle size distribution:The aerosol particle size was analyzed thrice using GALAI-CIS-50 particle size analyzer, i.e., during the first, second and fourth hour of the exposure period. The air samples from the chamber were passed through the cuvette of the aerosol module of the instrument which measured the aerosol particle size by laser based “Time of transition theory” and instantaneous data on mean particle size with standard deviation were obtained from the computer and the results were as follows.
Trial Number Sampling hour Particle size in micrometer
Mean ± SD
1 I 1.26 ± 0.95
2 II 1.27 ± 0.98
3 IV 1.20 ± 0.88
Overall mean ± SD 1.21 ± 0.98
Calculated Geometric standard deviation 2.46
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): The value for geometric standard deviation (GSD) for the test item is 2.46. This indicates that the size distribution of the aerosols is acceptable (GSD falls within the range of 1.5-3.0, as recommended by OECD guidance document no. 39 on acute inhalation testing). - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- The inhalation columns were eluted with Ethyl acetate. The concentration of Depanol I was determined by using Gas Chromatograph (GC) equipped with FID detector, auto sampler and a PC based data system
- Duration of exposure:
- 4 h
- Concentrations:
- Analyzed Concentration, mg of test item/L of chamber air
Mean ± SD: 4.95 ± 0.472 - No. of animals per sex per dose:
- 5 (Main study)
3 (Pre-study) - Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Toxic signs could not be ascertained four times at hourly intervals during the exposure period due to the special housing method. The observations for toxic signs and pre-terminal deaths were done immediately after exposure, while releasing the rats from the restrainers. The rats were observed twice after release of rats from the restrainers. Thereafter, the observations for toxic signs and pre-terminal deaths were done once daily during days 2 to 15.
Body weights were recorded once during the acclimatization period and on day 1 (pre-exposure), 2, 4, 8 (7 days of post exposure) and 15 (14 days of post exposure.
- Necropsy of survivors performed: Yes. - Preliminary study:
- A pre-study was conducted as per OECD 403 Traditional Protocol using 3 male and 3 female rats, the rats were exposed to the test item aerosol generated under the following conditions:
Test item concentration Undiluted test item
Atomizer used Glass
Atomizer Pressure 1.4 kg/cm2
Injection rate 0.4 mL/min.
Airflow rate 20 L/ min.
Sampling duration 10 min.
Sampling rate 10 L/min.
The suspendability / solubility test was not performed since the undiluted test item was used with an injection rate of 0.4 mL / min for the pre-study.
The animals were exposed in inhalation equipment with dynamic airflow.
The results of pre-study are given below.
G1 Undiluted test item 3 M/3F
1) Test item concentration# inChamber air, mg/L : 6.52 ± 1.06
2) Aerosol particle size (µm): 1.50 ± .1.34
*: Toxic signs could not be ascertained during the inhalation exposure period of four hours due to special housing method and the toxic signs recorded were at the time of release of animals from the restrainers. Tremors, slight salivation and nasal discharge were observed in two male and two female. Tremors and nasal discharge were observed in one male and one female on day1. The rats were normal from day2.
#: The test item concentration in the air inhalation sample columns was analysed using a validated analytical method.
The necropsy findings will be recorded in the raw data and included in the report.
Based on the pre-study result, the following dose is selected for the main study.
G1: Undiluted test item was used with an injection rate of 0.4 mL/min. - Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 4.95 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: nose only
- Mortality:
- There were no mortalities.
- Clinical signs:
- other: The clinical signs of toxicity were nasal discharge, slight ataxia, slight salivation and slight tremors immediately and approximately 1 hour after end of exposure on day 1 and all the rats were normal form day 2 onwards.
- Body weight:
- There was a slight decrease in body weight of five female and three male rats on day 2 when compared to their initial body weight. On day 4 there was a slight decrease in body weight of three female rats when compared to their initial body weight, however all the rats gained weight during 8th and 15th day weighing.
- Gross pathology:
- No abnormality was detected at necropsy in any of the rats.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute inhalation (4 hours) Lethal Concentration (LC50) value of Depanol I in Wistar rats is more than 4.95 mg/L of chamber air (maximum attainable concentration) in both male and female Wistar rats.
- Executive summary:
The inhalation toxicity of Depanol I was determined in 5 male and 5 female Wistar rats by exposure to aerosol of undiluted test item generated by glass atomizer with an injection rate of 0.4 mL/min. with 1.4 kg/cm2 of atomizer pressure. The rats were housed in special rat restrainers and were continuously exposed to the test item aerosol (nose only) for four hours in inhalation exposure chamber (dynamic state). The post treatment observation period was for 14 days. The aerosol sampled from the inhalation chamber for particle size analysis showed a mean aerosol particle size of 1.21 ± 0.98 micrometers. The generated aerosol particle distribution was uniform throughout the exposure period of four hours. The geometric standard deviation (GSD) value of the test item was 2.46, indicating that the aerosol was polydisperse. The fraction of aerosol with particle size of 3.90 micrometer was less than 97% and this fraction was considered to be inhalable. The analytically determined average concentration of Depanol I was 4.95 mg/L of chamber air. There were no pre-terminal deaths. The clinical signs of toxicity were nasal discharge, slight ataxia, slight salivation and slight tremors immediately and approximately 1 hour after end of exposure (Day1). The rats were normal from day 2 onwards.
The acute inhalation (4 hours) Lethal Concentration (LC50) value of Depanol I was more than 4.95 mg/L of chamber air (maximum attainable concentration) in both male and female Wistar rats. Based on the test results of the present study, the test item, Depanol I is not classified.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 4.95 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
A key oral toxicity study with Depanol I in Wistar rats was conducted according to the acute toxic class method (Advinus, 2012a). The test item suspended in corn oil was administered as oral gavage to overnight fasted 6 female rats at the dose of 2000 mg/kg body weight, whereas vehicle control group animals were administered corn oil. There were no toxic signs and pre-terminal deaths in treatment and control groups. All animals gained body weight during 14 days observation period. Necropsy at termination did not reveal abnormalities. Based on the results of the present study, the test item, Depanol I has an oral LD50 of >2000 mg/kg body weight and does not have to be classified as per CLP Regulation. In a supporting study, the LD50 of Depanol I in three solvents (Pinene-Camphor,Terpin hydrate and Flotol) was determined in mice after single oral exposure. The LD50 of Depanol I in Pinene-Camphor was 5000 mg/kg bw, in Terpin hydrate 6000 mg/kg bw and in Flotol 2000 mg/kg bw. It was concluded that the test item was not particularly toxic (relatively harmless).
A key acute inhalation toxicity with Depanol I was conducted in 5 male and 5 female Wistar rats by exposure to aerosol of undiluted test item generated by glass atomizer with an injection rate of 0.4 mL/min with 1.4 kg/cm2 of atomizer pressure (Advinus, 2012b). The rats were housed in special rat restrainers and were continuously exposed to the test item aerosol (nose only) for four hours in inhalation exposure chamber (dynamic state). The post treatment observation period was for 14 days. The aerosol sampled from the inhalation chamber for particle size analysis showed a mean aerosol particle size of 1.21 ± 0.98 micrometers. The generated aerosol particle distribution was uniform throughout the exposure period of four hours. The geometric standard deviation (GSD) value of the test item was 2.46, indicating that the aerosol was polydisperse. The fraction of aerosol with particle size of 3.90 micrometer was less than 97% and this fraction was considered to be inhalable. The analytically determined average concentration of Depanol I was 4.95 mg/L of chamber air. There were no toxic signs and pre-terminal deaths. No abnormality was detected in any of the rats. The acute inhalation (4 hours) LC50 value of Depanol I was more than 4.95 mg/L of chamber air (maximum attainable concentration) in both male and female Wistar rats. Based on the test results of the present study, the test item, Depanol I is not classified.
A key acute dermal toxicity test was conducted with Wistar rats (male and female) to determine the potential for Depanol I to produce toxicity from a short term exposure via the dermal route (Advinus, 2012c). The undiluted test item at the dose of 2000 mg/kg bw was applied directly to the clipped skin of the animal to cover about 10% of body surface under adhesive occlusion for 24 hours. After the 24 hour contact period, the dressing was removed and the applied area was washed initially with water and with Johnson’s Baby Soap and again with water. Washed animals were wiped dry with a cotton hand towel. After treatment in 5 female rats, 5 male rats were treated. All the rats were observed for clinical signs of toxicity, local skin reaction and mortality for 14 days post application. There were no clinical signs of toxicity, local skin reaction or mortality. There were no abnormalities detected at the necropsy. Based on the results of the present study, the LD50 was above 2000 mg/kg bw and the test item does not have to be classified.
Justification for selection of acute toxicity – oral endpoint
Key study with Depanol I
Justification for selection of acute toxicity – inhalation endpoint
Key study
Justification for classification or non-classification
Based on the available data, Depanol I does not have to be classified for acute toxicity according the EU labelling regulations Commission Directive 93/21/EEC or CLP regulation No. 1272/2008 of 16 December 2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.